Nombre del producto:5-Fluorooxindole

IUPAC Name:5-fluoro-2,3-dihydro-1H-indol-2-one

CAS:56341-41-4
Fórmula molecular:C8H6FNO
Pureza:95%+
Número de catálogo:CM148054
Peso molecular:151.14

Unidad de embalaje Stock disponible Precio($) Cantidad
CM148054-100g in stock ŵȡǶ
CM148054-500g in stock ǜȡNJ

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :56341-41-4
Fórmula molecular:C8H6FNO
Punto de fusión:-
Código de sonrisas:C1=C2C(=CC=C1F)NC(=O)C2
Densidad:
Número de catálogo:CM148054
Peso molecular:151.14
Punto de ebullición:307.2°C at 760 mmHg
Nº Mdl:MFCD02179598
Almacenamiento:Keep in a tight container and store at ambient temperature

Category Infos

Indolinones
Indolinone derivatives have in common the presence of a hydrogen bond between the C-2 carbonyl and a hydrogen donor in a side chain, generally a pyrrole ring. Indolinone displays very promising antitumor properties by inhibiting various kinase families.

Column Infos

Vorolanib
EyePoint Pharmaceuticals announced on December 4th announced positive topline results of its Phase 2 DAVIO 2 trial of EYP-1901, an investigational sustained delivery maintenance treatment for wet age-related macular degeneration (wet AMD) combining vorolanib, a selective tyrosine kinase inhibitor with bioerodible Durasert E™. Vorolanib brings a new mechanistic approach to the treatment of VEGF-mediated retinal diseases as a pan-VEGF receptor blocker, blocking all VEGF isoforms. Vorolanib features reduced off-target binding and at clinically relevant doses does not inhibit Tie-2, a critical pathway associated with vascular stability, which may result in an improved efficacy. Further, in an in-vivo model of retinal detachment, vorolanib demonstrated neuroprotection, and potential antifibrotic benefits.